Skip to main content
OpenTrials
Completed

NCT Number: NCT02138539

Evaluation of an Herbal-Based De-Pigmenting System

The purpose of this study is to evaluate the effectiveness and tolerability of an herbal de-pigmenting regimen applied to one side of the face compared with hydroquinone applied to the other side of the face in treating mottled hyperpigmentation and melasma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Sadick Research Group

New York, 10075, United States

About this study

This clinical study is being conducted in order to evaluate the effectiveness and tolerability of a de-pigmenting regimen when used by subjects with mild to severe mottled hyperpigmentation and melasma. Efficacy will be assessed using visual grading, device measurements and digital photography. Tolerance and safety will be evaluated by grading for objective and subjective signs of irritation, and the incidence and severity of adverse events. Efficacy and tolerance of this product are compared to that of Hydroquinone, which is applied to one side of the subject's face while the herbal de-pigmenting regimen is applied to the other side of the face.

The two product pigmentation reducing herbal regimen is based on the novel concept of inhibiting all 14 major and the 3 branch steps in the melanin cascade.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female age 30-65
  • Must be in good general health
  • Must be willing to use sunscreen on the face daily
  • Must be willing to avoid tanning beds and excessive exposure to direct sunlight
  • Must be willing to continue using regular cosmetic regimen

Exclusion criteria

  • Nursing pregnant/ planning to become pregnant during the course of the study
  • Using a medication that increases sensitivity to sunlight including doxycycline, minocycline, tetracycline, ciprofloxin, hydrochlorothiazide, and sulfonamides.
  • Any known allergies/sensitivities to facial skincare products, anti-aging products, de-pigmenting products, or products containing hydroquinone
  • Usage of any new skincare products during the course of the study
  • Presence of atopic dermatitis or psoriasis on the face
  • Uncontrolled diabetes, hypertension, hypothyroidism, hyperthyroidism
  • TCA or other deep peels within 1 year or medium to light peels within 3 months prior to starting the study
  • Facial/laser treatment within the last 3 months
  • Facial cosmetic surgery within the last 12 months
  • Use of product, topical, or systemic medication, known to affect dyschromia, having "whitening" or anti-aging properties
  • Physical skin conditions such as excessive hair, scarring, tattoos that might impair evaluations of the test sites
  • Active hepatitis, immune deficiency, or autoimmune disease

Treatment and study plan

Herbal depigmenting agent (Epionce)

Other

A two product herbal pigmentation reducing regimen is applied twice a day to either the left or right side of the face for a duration of 4 months.

Other names: Epionce

Hydroquinone

Drug

Hydroquinone 4% is applied twice a day to either the left or right side of the face for a duration of 4 months.

Primary outcomes

  1. Melanin Index

    Time frame: 6 months

    The melanin index of the skin will be measured at baseline and at each follow-up visit with a non-invasive device. At the end of the study, the change of the Melanin index over a period of 6 months will be calculated.

Secondary outcomes

  1. Irritation

    Time frame: Baseline, 1 month, 2 month, 4 month, 6 months

    Both objective irritation (erythema, edema, peeling, scaling/dryness) and subjective irritation (burning/stinging, itching, dry/tight feeling) will be measured at each visit via visual grading assessments and subject questionnaires.

Sponsors and collaborators

Lead sponsor

Sadick Research Group

Other

Collaborators

  • Episciences, Inc.

Registry information

Official study title

A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
May 14, 2014
Registry last updated
Nov 18, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.